Aspirin versus placebo on estrogen levels in postmenopausal women: a double-blind randomized controlled clinical trial
Estrogen is involved in the pathogenesis of breast and gynecological cancers. Regular use of aspirin reduces estrogen levels. The present study aimed to evaluate the effect of aspirin on estrogen levels in pos...
Source: BMC Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Mohammad Bagher Oghazian, Nooshin Shirzad, Mahdi Ahadi, Shalaleh Eivazi Adli, Samaneh Mollazadeh and Mania Radfar Tags: Research Source Type: research
More News: Aspirin | Cancer | Cancer & Oncology | Clinical Trials | Drugs & Pharmacology | Mania | Study | Women